| Authors: |
Ahmad A; University of Manchester, United Kingdom. Electronic address: amais.ahmed@manchester.ac.uk., Pepin X; AstraZeneca, United Kingdom., Aarons L; University of Manchester, United Kingdom., Wang Y; University of Manchester, United Kingdom., Darwich AS; Royal Institute of Technology, Stockholm, Sweden., Wood JM; AstraZeneca, United Kingdom., Tannergren C; AstraZeneca, United Kingdom., Karlsson E; AstraZeneca, United Kingdom., Patterson C; AstraZeneca, United Kingdom., Thörn H; AstraZeneca, United Kingdom., Ruston L; AstraZeneca, United Kingdom., Mattinson A; AstraZeneca, United Kingdom., Carlert S; AstraZeneca, United Kingdom., Berg S; AstraZeneca, United Kingdom., Murphy D; AstraZeneca, United Kingdom., Engman H; AstraZeneca, United Kingdom., Laru J; AstraZeneca, United Kingdom., Barker R; AstraZeneca, United Kingdom., Flanagan T; AstraZeneca, United Kingdom., Abrahamsson B; AstraZeneca, United Kingdom., Budhdeo S; AstraZeneca, United Kingdom., Franek F; AstraZeneca, United Kingdom., Moir A; AstraZeneca, United Kingdom., Hanisch G; AstraZeneca, United Kingdom., Pathak SM; Certara, Simcyp Division, United Kingdom., Turner D; Certara, Simcyp Division, United Kingdom., Jamei M; Certara, Simcyp Division, United Kingdom., Brown J; Bristol-Myers Squibb, United Kingdom., Good D; Bristol-Myers Squibb, United Kingdom., Vaidhyanathan S; Bristol-Myers Squibb, United Kingdom., Jackson C; Bristol-Myers Squibb, United Kingdom., Nicolas O; Sanofi, United States., Beilles S; Sanofi, United States., Nguefack JF; Sanofi, United States., Louit G; Sanofi, United States., Henrion L; Sanofi, United States., Ollier C; Sanofi, United States., Boulu L; Sanofi, United States., Xu C; Sanofi, United States., Heimbach T; Novartis, United States., Ren X; Novartis, United States., Lin W; Novartis, United States., Nguyen-Trung AT; Novartis, United States., Zhang J; Novartis, United States., He H; Novartis, United States., Wu F; Novartis, United States., Bolger MB; Simulation Plus, Inc., United States., Mullin JM; Simulation Plus, Inc., United States., van Osdol B; Simulation Plus, Inc., United States., Szeto K; Simulation Plus, Inc., United States., Korjamo T; Orion Pharma, Finland., Pappinen S; Orion Pharma, Finland., Tuunainen J; Orion Pharma, Finland., Zhu W; Merck Research Laboratories, Merck & Co., United States., Xia B; Merck Research Laboratories, Merck & Co., United States., Daublain P; Merck Research Laboratories, Merck & Co., United States., Wong S; Pfizer, United States., Varma MVS; Pfizer, United States., Modi S; Pfizer, United States., Schäfer KJ; Boehringer-ingelheim, Germany., Schmid K; Boehringer-ingelheim, Germany., Lloyd R; GlaxoSmithKline, United Kingdom., Patel A; GlaxoSmithKline, United Kingdom., Tistaert C; Janssen, Belgium., Bevernage J; Janssen, Belgium., Nguyen MA; Johannes Gutenberg University of Mainz, Germany., Lindley D; AbbVie, Germany., Carr R; AbbVie, Germany., Rostami-Hodjegan A; University of Manchester, United Kingdom; Certara, Simcyp Division, United Kingdom. |
